Derivatives of p-guanidinobenzoic acid and pharmaceutical agents containing them as an active ingredient
AssigneeOno Pharmaceutical Co., Ltd.
InventorsKatsuhiro Imaki, Yoshinobu Arai, Hiroyuki Ohno
Life of this patent
Estimating the term…
Loading patent…
AssigneeOno Pharmaceutical Co., Ltd.
InventorsKatsuhiro Imaki, Yoshinobu Arai, Hiroyuki Ohno
Estimating the term…
A derivative of p-guanidinobenzoic acid of the general formula (IA): ##STR1## wherein Y represents an oxygen atom or a sulfur atom and (a) when Y is an oxygen atom, (R.sup.1).sub.m is selected from the group consisting of: 5-(4-guanidinobenzoyloxy)-3-methoxymethyl, 3,5-dicarboxy, 3,5-bis(isopropoxycarbonyl), 3,5-bistrifluoromethyl, 3-acetyl, 3,5-bis(N-ethylcarbamoyl), and 3,5-bis(N-propylcarbamoyl); (b) when Y is a sulfur atom, (R.sup.1).sub.m is selected from the group consisting of: 2-methyl, 3-methyl, 4-fluoro, 2-chloro, 3-chloro, 2,5-dichloro 2,6-dichloro, 3,4-dichloro, 2-bromo, 2-methoxycarbonyl, and 4-(N,N-diethylaminosulfonyl); or an acid addition salt of said derivative. A method for the treatment or prevention of diseases induced by abnormal enhancing of degradation of proteins by the action of elastase in mammals subject to or suffering therefrom, including the step of administering an effective amount of a p-guanidinobenzoic acid as described herein, is also disclosed.
A method for the treatment or prevention of diseases induced by abnormal enhancing of degradation of proteins by the action of elastase in mammals subject to or suffering therefrom, which comprises the administration of an effective amount of at least one derivative of p-guanidinobenzoic acid of formula (IB):
A derivative of p-guanidinobenzoic acid of the general formula (IA):
Dependencies are inferred from the claim text.